Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 0 | 0 | 0 | 0 | 209 |
| Gross Profit | N/A | N/A | N/A | 0 | 209 |
| Operating Expenses | 5,984 | 6,040 | 6,937 | 4,902 | 5,357 |
| Operating Income | -5,984 | -6,040 | -6,937 | -4,902 | -5,148 |
| Interest Expense | 187 | 28 | 43 | 378 | 230 |
| Other Income | -432 | 1 | 0 | -459 | -695 |
| Pre-tax Income | -6,603 | -6,067 | -6,980 | -5,739 | -6,073 |
| Net Income Continuous | -6,603 | -6,067 | -6,980 | -5,739 | -6,073 |
| Net Income | $-6,603 | $-6,067 | $-6,980 | $-5,739 | $-6,073 |
| EPS Basic Total Ops | -0.32 | -0.30 | -0.34 | 8.65 | -4.81 |
| EPS Basic Continuous Ops | -0.32 | -0.30 | -0.34 | 8.65 | -4.81 |
| EPS Diluted Total Ops | -0.32 | -0.30 | -0.34 | 8.65 | -4.81 |
| EPS Diluted Continuous Ops | -0.32 | -0.30 | -0.34 | 8.65 | -4.81 |
| EBITDA(a) | $-5,866 | $-5,901 | $-6,806 | $-4,508 | $-4,914 |